Market cap: $104,580,749,694
Exchange: NYS
Sector: Health Technology
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
Company Name
Bristol-Myers Squibb Co.
Average Volume (10 days)
10,289,249
Average Volume (30 days)
18,824,384
Moving Average (50 days)
$51.57
Moving Average (200 days)
$51.05
Ex-Divided Date
Apr 4, 2024
Dividend Yield
0.0446
P/E Ratio
13.0319
Market Cap
104,580,749,694
Shares Outstanding
2,026,758,715
52-Week High Split Adjust Only
68.01
52-Week Low Split Adjust Only
47.03
Employee Count
34,300
Beta
0
Next Earnings Date
2024-04-25
TTM Dividend Rate Per Share
2.3015
Past 5 days
-0.01%
Past 30 days
-0.03%
Past 3 months
0.02%
Past 6 months
-0.07%
Past year
-0.24%
Past 2 years
-0.29%
Past 5 years
0.33%
Max % Change
2.36%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Co. | BMY | 3.43 | 3.90 | 8.8 | 3.43 | 4.21 |
| Peer Avg | N/A | 4.94 | 9.66 | 8.5 | 4.94 | 5.51 |
| Lilly(Eli) & Co | LLY | 7.52 | 27.77 | 25.2 | 7.52 | 8.03 |
| Johnson & Johnson | JNJ | 5.29 | 6.77 | n/a | 5.29 | 5.40 |
| Merck & Co Inc | MRK | 4.00 | 7.13 | 11.7 | 4.00 | 4.51 |
| Abbvie Inc | ABBV | 3.98 | 14.58 | n/a | 3.98 | 5.49 |
| Astrazeneca plc - ADR | AZN | 5.40 | 10.33 | n/a | 5.40 | 5.85 |
| Novartis AG - ADR | NVS | 4.37 | 4.32 | n/a | 4.37 | 5.05 |
| Abbott Laboratories | ABT | 5.55 | 6.18 | 23.1 | 5.55 | 5.82 |
| Pfizer Inc. | PFE | 4.88 | 3.16 | 10.2 | 4.88 | 5.46 |
| AMGEN Inc. | AMGN | 5.43 | 14.65 | 14.6 | 5.43 | 6.31 |
| Sanofi - ADR | SNY | 2.93 | 1.74 | n/a | 2.93 | 3.17 |